Research output per year
Research output per year
Personal profile
Headline
PROFESSOR | Genetics and Genomic Sciences
Biography
I am a Genetic Epidemiologist in the Department of Genetics and Genomic Sciences. I have extensive experience in designing studies aimed to identify genetic risk factors associated with complex diseases, such as type 2 diabetes, obesity, cardiovascular disease and Crohn’s disease, as well as with response to therapeutic and lifestyle interventions. Multi-Disciplinary Training Areas Clinical Research Education Program [CLR], Genetics and Genomic Sciences [GGS] Education MSc, Tel Aviv University PhD, Tel Aviv University Tufts University Weizmann Institute of Science
Fingerprint
Dive into the research topics where Inga Peter is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Dietary Intake of Pregnant Women with and without Inflammatory Bowel Disease in the United States
Olendzki, B. C., Hsiao, B. S., Weinstein, K., Chen, R., Frisard, C., Madziar, C., Picker, M., Pauplis, C., Maldonado-Contreras, A. & Peter, I., Jun 2023, In: Nutrients. 15, 11, 2464.Research output: Contribution to journal › Article › peer-review
Open Access -
Immunological Features of LRRK2 Function and Its Role in the Gut-Brain Axis Governing Parkinson's Disease
Peter, I. & Strober, W., 2023, In: Journal of Parkinson's Disease. 13, 3, p. 279-296 18 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Perspective on the current state of the LRRK2 field
Taymans, J. M., Fell, M., Greenamyre, T., Hirst, W. D., Mamais, A., Padmanabhan, S., Peter, I., Rideout, H. & Thaler, A., Dec 2023, In: npj Parkinson's Disease. 9, 1, 104.Research output: Contribution to journal › Article › peer-review
Open Access -
Polygenic risk scores point toward potential genetic mechanisms of type 2 myocardial infarction in people with HIV
Lee, W. J., Cheng, H., Whitney, B. M., Nance, R. M., Britton, S. R., Jordahl, K., Lindstrom, S., Ruderman, S. A., Kitahata, M. M., Saag, M. S., Willig, A. L., Burkholder, G., Eron, J. J., Kovacic, J. C., Björkegren, J. L. M., Mathews, W. C., Cachay, E., Feinstein, M. J., Budoff, M., Hunt, P. W., & 12 others, 15 Jul 2023, In: International Journal of Cardiology. 383, p. 15-23 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
International Parkinson’s Disease Genomics Consortium (IPDGC), Dec 2022, In: Molecular Neurodegeneration. 17, 1, 48.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations
Press/Media
-
Findings on Heart Attack Reported by Investigators at Icahn School of Medicine at Mount Sinai (Polygenic Risk Scores Point Toward Potential Genetic Mechanisms of Type 2 Myocardial Infarction In People With Hiv)
Inga Peter, Ke Hao, Jason Kovacic & Johan Bjorkegren
31/07/23
1 item of Media coverage
Press/Media
-
Sequencing an Ashkenazi reference panel supports population-targeted personal genomics and illuminates Jewish and European origins
30/11/22
1 item of Media coverage
Press/Media
-
-
WHAT WE FUND: $19.7 MILLION IN NEW GRANTS FOR PARKINSON'S RESEARCH
28/12/20
1 item of Media coverage
Press/Media